Responding to client needs within its rapidly expanding specialty drug management practice, the Chelko Consulting Group recently welcomed Kelly Prymicz, PharmD, RPh.

Prymicz comes to Chelko from the Louis Stokes Veterans Administration Medical Center where she most recently served as a quality assurance clinical pharmacy specialist. While with the VA, Prymicz was a voting member of the Pharmacy & Therapeutics Committee, on which she chaired its Medication Management subcommittee.

Prymicz will help clients better manage the prescription drug spend in their medical TPA and PBM administered benefits. Her deep expertise and passion for treatment efficacy, as they relate to specialty drug therapies, will help ensure plan members receive the right medication, for the right condition, in the right way.

Established in 2001 to provide high value, conflict-free, and transparent medical, life, and disability benefits consulting services to medium- and large-size employers, Chelko has recently seen tremendous growth assisting clients in reducing costs on the specialty drug front.

Applying its typical data-driven management process known for producing actionable insight and impressive results, the firm works with a growing list of clients to reduce and avoid unnecessary costs in this area of rapidly rising health plan spend. Strengthened by its strategic partnership with Archimedes, Chelko empowers clients by integrating the latest technology and analytics to help control the growing cost of traditional and specialty drugs across the pharmacy and medical benefits.